Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

Trading Update

29 Apr 2021 07:00

RNS Number : 9817W
Devro PLC
29 April 2021
 

Devro plc

 

Trading Update

 

Devro plc ("Devro" or the "Company"), one of the world's leading manufacturers of collagen products for the food industry, issues the following trading update for the period 1 January 2021 to the current date ahead of its Annual General Meeting today.

Current trading

Q1 2021 edible collagen volumes increased 4.6% compared to the prior year driven by continued good underlying momentum and execution of our growth initiatives. Emerging markets were up 15% led by strong growth in China, South East Asia and Latin America. Mature markets were flat on the prior year, an improvement on the trends seen in 2020. Japan and North America both delivered strong growth but this was offset by lower demand in the UK & Ireland which had benefitted from elevated retail volumes in March 2020 as the pandemic took hold.

Financial position

The Group delivered strong cashflows during Q1, ending the quarter with comparable levels of leverage to 2020 year-end, including the dividend payment made in January 2021.

The Group repaid the US$25 million private placement due on the 19 April 2021 using a combination of available cash resources and RCF drawings. Post this repayment the Group maintains significant liquidity but with a lower average cost of borrowing.

The Group's remaining debt facilities consist of a committed ÂŁ105 million Revolving Credit Facility (RCF), which expires in 2023, and US$75 million of private placements expiring April 2024 (US$50 million) and 2026 (US$25 million).

Outlook

We are encouraged by the good volume growth performance in Q1 and, whilst we expect this trend to continue we remain mindful of the uncertainties arising from the ongoing COVID-19 pandemic and likely foreign exchange headwinds. As a result, our expectations for 2021 remain unchanged.

ENDS 

Contacts:

 

Devro plc

Rutger Helbing

Chief Executive Officer

Tel: 020 3865 7637

Rohan Cummings

Chief Financial Officer

Tel: 020 3865 7637

 

FTI Consulting

Richard Mountain

Nick Hasell

Tel: 020 3727 1340

 

Dividend: In the Company's announcement on 2 March 2021 of its results for the year ended 31 December 2020, the Board proposed a final dividend of 6.3p per share (the "2020 Final Dividend") to be paid on 1 October 2021, to those shareholders on the register at 20 August 2021, subject to shareholder approval at the Annual General Meeting in April 2021. The Board has subsequently resolved to recommend the payment of the 2020 Final Dividend be brought forward from 1 October 2021 to 20 July 2021, to those shareholders on the register at 11 June 2021.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEFFWAEFSEDL
Date   Source Headline
24th Mar 20174:00 pmRNS2016 Annual Report
15th Mar 20175:14 pmRNSHolding(s) in Company
6th Mar 20177:00 amRNSNotification of Board changes
6th Mar 20177:00 amRNSFinal Results
21st Feb 20172:43 pmRNSHolding(s) in Company
25th Jan 20174:36 pmRNSHolding(s) in Company
11th Jan 20177:00 amRNSYear End Trading Update
21st Dec 20167:00 amRNSAppointment of Non-Executive Director
8th Dec 20164:52 pmRNSDirector/PDMR Shareholding
8th Dec 20164:15 pmRNSDirector/PDMR Shareholding
7th Dec 20164:32 pmRNSDirector/PDMR Shareholding
25th Nov 20163:01 pmRNSDirector/PDMR Shareholding
24th Nov 20163:14 pmRNSBlock listing Interim Review
23rd Nov 20161:32 pmRNSDirector/PDMR Shareholding
14th Nov 201611:36 amRNSDirector/PDMR Shareholding
10th Nov 20164:12 pmRNSDirector/PDMR Shareholding
10th Nov 20164:07 pmRNSDirector/PDMR Shareholding
10th Nov 201610:51 amRNSDirector/PDMR Shareholding
10th Nov 20167:00 amRNSTrading Update
21st Sep 20165:05 pmRNSHolding(s) in Company
18th Aug 20162:24 pmRNSDirector/PDMR Shareholding
18th Aug 20162:23 pmRNSDirector/PDMR Shareholding
11th Aug 201610:41 amRNSHolding(s) in Company
8th Aug 20162:15 pmRNSDirector/PDMR Shareholding
3rd Aug 20167:00 amRNSHalf-year Report
21st Jul 20163:53 pmRNSHolding(s) in Company
30th Jun 20167:00 amRNSTotal Voting Rights and Share Capital
23rd Jun 20163:16 pmRNSDirector/PDMR Shareholding
10th Jun 201610:18 amRNSHolding(s) in Company
25th May 20165:38 pmRNSHolding(s) in Company
24th May 201611:53 amRNSBlock listing Interim Review
23rd May 20163:33 pmRNSDirector/PDMR Shareholding
13th May 20163:33 pmRNSDirector Declaration
5th May 20164:23 pmRNSHolding(s) in Company
28th Apr 20163:54 pmRNSDirector/PDMR Shareholding
27th Apr 20164:45 pmRNSResults of Annual General Meeting
27th Apr 20167:00 amRNSTrading Update
8th Apr 20163:33 pmRNSNotification of Transactions of Directors
30th Mar 20167:00 amRNSAnnual Financial Report
29th Mar 201612:35 pmRNSFurther re: Group Finance Director Retirement
23rd Mar 201612:52 pmRNSNotification of Transactions of Directors
1st Mar 20167:00 amRNSFinal Results
17th Feb 201610:13 amRNSHolding(s) in Company
9th Feb 201612:56 pmRNSHolding(s) in Company
9th Dec 20157:00 amRNSGroup Finance Director
27th Nov 20154:30 pmRNSNotification of Transactions of Directors
24th Nov 20158:23 amRNSBlock Listing Six Monthly Return
17th Nov 20157:01 amRNSGroup Finance Director Retirement
17th Nov 20157:00 amRNSTrading update
21st Oct 20157:00 amRNSNotice of trading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.